DongKoo Bio & Pharma Co., Ltd. (KOSDAQ: 006620)
South Korea
· Delayed Price · Currency is KRW 5,040.00
-20.00 (-0.40%)
Jan 22, 2025, 3:00 PM KST
DongKoo Bio & Pharma Revenue
DongKoo Bio & Pharma had revenue of 66.18B KRW in the quarter ending September 30, 2024, with 25.19% growth. This brings the company's revenue in the last twelve months to 253.71B, up 25.78% year-over-year. In the year 2023, DongKoo Bio & Pharma had annual revenue of 215.69B with 10.62% growth.
Revenue (ttm)
253.71B
Revenue Growth
+25.78%
P/S Ratio
0.55
Revenue / Employee
665.91M
Employees
381
Market Cap
138.15B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 292.86T |
| SK hynix | 57.73T |
| LG Energy Solution | 27.17T |
| Samsung Biologics Co.,Ltd. | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Kia Corporation | 104.63T |
| Celltrion | 2,876.25B |
| KB Financial Group | 14.11T |